Seeking Alpha

M. E. Garza's  Instablog

M. E. Garza
Send Message
M.E. Garza is one of the founders of the biotech and healthcare sector news portal BioMedReports.com. He believes in getting the news from credible sources on the street and often reaches out to CEOs and newsmakers directly for interviews and discussions about their companies. Since he began... More
My company:
BioMedReports.Com
My blog:
Daily Info Feeds and Updates
  • Nolvelos to present to present new NOV-002 preclinical data in April 2010 0 comments
    Feb 26, 2010 10:00 AM | about stocks: CLRB
    We reached out to Harry S. Palmin, the CEO of Novelos Therapeutics (NVLT.OB) after the drug developer said its recent phase-3 trial for a new lung-cancer drug candidate failed after showing no benefits relative to traditional treatments earlier this week.

    The results for its NOV-002 cancer therapy in patients with advanced non-small cell lung cancer were received Feb. 23. and many were shocked to hear the news, especially after the CEO and many top analysts had been so bullish on the Phase III drug trial.

    “Upon evaluation and review of the data contained in the report, we determined that the primary endpoint of improvement in overall survival was not met in the trial,” the company said in a regulatory filing last Wednesday.

    Palmin responded to me via e-mail that the company will conduct a thorough analysis of all the data, and expect to present detailed Phase 3 lung cancer trial results later this year.

    He added:

    "Meanwhile, we are scheduled to present new NOV-002 preclinical data at the AACR Annual Meeting in April 2010, and we are on track for results from a NOV-002 Phase 2 breast cancer trial in 3Q 2010.  We are also on track to initiate a Phase 2 hepatitis C trial shortly, with our second compound NOV-205."

     



    Disclosure: No positions
    Stocks: CLRB
Back To M. E. Garza's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

  • Hearing some interesting developments on the horizon for $NWBO. Did an article on them yesterday. Looks promising. http://bit.ly/NWBOnews
    Jul 12, 2011
  • ($RXPC.PK 3 of 3) If it were bad news, chances are they'd have something by now, since delisting decisions are usually handed down quickly.
    Apr 19, 2011
  • ($RXPC.PK 2 of 3) a listing extension would go until July [when the stock would have to be over $1 to continue being listed on Amex].
    Apr 19, 2011
More »

Latest Comments


Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.